Untitled-17
Donate Now
  • Home
  • About us
    • About us
    • What we do
      • Our achievements
      • The Future
    • Who we are
      • Trustees
      • Our Team
      • Patrons
      • Annual Accounts
    • Partnerships
    • Vacancies
    • News
  • Education
    • Pelican OReCO
      • OReCO On-line Resources
      • OReCO Partners & Sponsors
      • Pelican OReCO Workshops
    • Pelican IMPACT
      • IMPACT – Completion & Evaluation
      • Workshops
      • IMPACT – Online resources
      • IMPACT – Partners and Sponsors
    • SPECC
      • SPECC – Completion & Evaluation
      • Workshops
      • SPECC – Online resources
      • SPECC – Partners and Sponsors
    • LOREC
    • TIPTOP
      • Workshops
      • TIPTOP – Online resources
      • Bob’s story (prostate cancer)
      • Andrew’s story (prostate cancer)
      • Alan’s story (prostate cancer)
      • Raymond’s story (prostate cancer)
    • LARS
    • Sponsors
      • Become a sponsor
    • Request a course or topic
    • Give us feedback
    • Previous courses
  • Films
    • Surgical videos
  • Research
    • Current Research
    • Completed Research
      • Bowel cancer research
        • POLARS
        • MERCURY 2 (Low Rectal Cancer Study)
        • Deferral of surgery study
        • TATME
        • IMPRESS
        • TRIGGER
        • Papers of interest
        • Timing of surgery
        • AMSOEC
        • MINSTREL
        • Completed research
          • Perineal wound healing registry
          • Beyond TME
          • Validation of the LARS score
          • MARVEL: Evaluation of EMVI positive rectal cancer
          • FLEX
          • TME Physical Simulation Model
          • Total Mesorectal Excision (TME)
          • MERCURY research programme
      • Liver cancer research
        • Completed research
          • EORTC studies
        • SERENADE
        • Papers of interest
      • Peritoneal malignancy research
        • Colorectal Peritoneal Malignancy Database
        • Pseudomyxoma Pathology Atlas
    • Previous Research Areas
      • Prostate Cancer Research
        • Prostate cancer
        • Focal therapy and HIFU research
        • MRI research for prostate cancer
        • Prostate cancer colloquiums
        • FORECAST
        • Trachtomap
        • Papers of interest
      • Bladder cancer research
        • Bladder cancer
        • Papers of interest
    • Clinical trials
    • Information for research applicants
      • Peer Review Panel Terms of Reference
      • Research Review Panel
      • Research Grant Application Guidance Notes
      • Terms and conditions of grants
      • Animals in medical research
      • Research costs
  • For Patients
    • Patient stories
      • Anthony’s story (bowel cancer)
      • Elena’s story (bowel cancer)
      • Terry’s story (liver cancer)
      • Derrick’s story (liver cancer)
      • Alex’s story (colorectal cancer)
      • Cheryll’s story (rectal cancer)
      • Eileen’s story
      • Richard’s story – irrigation
      • Tom’s story – complete response
      • Advanced metastatic bowel cancer
    • What is an MDT?
      • What an MRI reveals
      • Reporting cancer outcomes
    • Bowel cancer
      • Our bowel cancer team
      • About bowel cancer treatment – TME
      • April – Bowel Cancer Awareness Month
      • Low rectal cancer
      • Complete response to chemoradiotherapy in rectal cancer
      • Frequently asked questions about bowel cancer
      • Irrigation for colostomies
      • A patient’s advice
      • Symptom checker
      • Bowel cancer – useful contacts
    • Liver cancer
      • Our liver cancer team
      • About liver cancer treatment
      • Interventional radiology
      • Liver cancer – frequently asked questions
      • Carcinoid and neuroendocrine tumours
      • Liver cancer – want to read more?
    • Pseudomyxoma peritonei
    • Getting a second opinion
    • Clinical trials
      • Current clinical trials
    • Tell us your story
    • Still got questions about cancer?
    • Links
  • Support us
    • Make a donation
      • Make a donation
      • Shares
      • In memory
    • Fundraise for us
      • Our fundraisers
      • Fundraising ideas
      • Fundraising challenges
      • Fundraising resources
    • Leave a Gift in your Will
    • Become a Corporate Partner
    • Trusts, Foundations & Philanthropy
    • Tell us your story
  • Contact us

Completed Research

The following research projects have now completed:

Bowel Cancer

MERCURY

This study led by Professor Gina Brown investigated whether radiologists could use MRI scans to predict when rectal cancer could be successfully treated with surgery alone or whether there was a risk of tumour being left behind. The study changed practice worldwide and was a key factor in shaping how clinicians treat rectal cancer today. Click here for more information

MERCURY 2

This study built on the success of MERCURY but focused on the MRI assessment of low rectal cancers (within 6cm of the anus). The study showed it was possible to reduce the chance of cancer being left behind after surgery and has changed the way radiologists report MRI scans. Click here for more information

Extramural venous invasion in rectal cancer

This project looked at extramural venous invasion (tumour spread into the veins) on both MRI scans and under the microscope in patients with rectal cancer to assess how this affected their survival. Click here for more information

EXPERT-C

This study investigated whether adding cetuximab to standard chemoradiotherapy for rectal cancer improved patients’ survival. Click here for more information

AMSOEC

This study looked at patients with early rectal cancer to investigate whether features of the tumour seen under the microscope could predict whether the tumour had spread to the lymph nodes (glands). Click here for more information

FLEX

This study investigated a new technique to remove benign polyps from the bowel, without the need for a major bowel resection, using a combination of endoscopy and keyhole surgery. Click here for more information

6 vs 12

This study investigated whether it was better to wait 6 weeks or 12 weeks after chemoradiotherapy for rectal cancer before operating. Standard care is now to wait longer after treatment before operating.

Deferral of surgery

This study investigated the outcomes in patients with rectal cancer who had a “complete response” (where the tumour disappears completely) after chemoradiotherapy.

MRI-Exenterative surgery

This study investigated whether MRI scans could assess the spread of advanced rectal cancer to help plan extenterative surgery (radical surgery to remove the cancer along with any adjacent organs or structure).

TaTME

This study investigated Transanal Total Mesorectal Excision (TaTME) – an operation for rectal cancer which involves removing the lower part of the rectum from “below”, i.e. through the anus rather than the traditional approach through the abdomen. Click here for more information

MINSTREL

This study focused on early rectal cancer and investigated whether MRI could help make the decision between whether patients needed a local excision of the tumour (from inside the bowel) or a radical operation to remove the entire rectum. Click here for more information

LOREC-APE

This study investigated national practices in carrying out abdomino-perineal excision (APE) surgery (removal of the rectum and anus) for patients with cancer very low in the rectum. The study focused on the method of closing the wound where the anus used to be to assess which method was best.

WISE

This study investigated whether it was possible to distinguish between bowel cancers in the sigmoid colon from those in the rectum by looking at the appearance of the bowel on MRI scans. This is important as tumours in each location are treated differently.

Stay in touch

Sign up to hear from us
Donate Now

© 2023 Pelican Cancer Foundation - all rights reserved

  Registered Charity Number: 1141911 -  Privacy Policy